The metabolic syndrome, thiazolidinediones, and implications for intersection of chronic and inflammatory disease-Reference-Cited by-同舟云学术

The metabolic syndrome, thiazolidinediones, and implications for intersection of chronic and inflammatory disease

Published:2022-01 Issue: Volume:55 Page:101409
ISSN:2212-8778
Container-title:Molecular Metabolism
language:en
Short-container-title:Molecular Metabolism

Author:

Colca Jerry R.^ORCID,Scherer Philipp E.

Funder

National Institutes of Health

National Institute on Aging

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference95 articles.

1. The Seats and Causes of Diseases Investigated by Anatomy (De Sedibus et Causis Morborum per Anatomen indagata);Morgagni,1765

2. The metabolic syndrome: a glance at its history;Sarafidis;Journal of Hypertension,2006

3. History of nonalcoholic fatty liver disease;Lonardo;International Journal of Molecular Sciences,2020

4. Is type 2 diabetes an adiposity-based metabolic disease? From the origin of insulin resistance to the concept of dysfunctional adipose tissue Eating and Weight Disorders - studies on Anorexia, Bulimia and Obesity;Sbraccia,2021

5. Role of insulin resistance in human disease;Reaven;Diabetes,1988

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin sensitizers in 2023: lessons learned and new avenues for investigation;Expert Opinion on Investigational Drugs;2023-09-02

2. Biomarkers of glucose homeostasis as mediators of the relationship of body mass index and waist circumference with COVID-19 outcomes among postmenopausal women: The Women’s Health Initiative;Clinical Nutrition;2023-09

3. An Egg White-Derived Peptide Enhances Systemic Insulin Sensitivity and Modulates Markers of Non-Alcoholic Fatty Liver Disease in Obese, Insulin Resistant Mice;Metabolites;2023-01-24

4. Novel thiazolidinedione analog reduces a negative impact on bone and mesenchymal stem cell properties in obese mice compared to classical thiazolidinediones;Molecular Metabolism;2022-11

5. PPAR-γ Partial Agonists in Disease-Fate Decision with Special Reference to Cancer;Cells;2022-10-13